University of Oxford
π¬π§United Kingdom
- Country
- π¬π§United Kingdom
- Ownership
- Private
- Established
- 1096-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.ox.ac.uk
Study of Heart and Renal Protection
Phase 4
Completed
- Conditions
- Kidney Disease, Chronic
- Interventions
- First Posted Date
- 2005-08-01
- Last Posted Date
- 2012-02-01
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 9438
- Registration Number
- NCT00125593
- Locations
- π¬π§
Clinical Trial Service Unit & Epidemiological Studies Unit, University of Oxford, Oxford, United Kingdom
Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine
Phase 3
Completed
- Conditions
- Cardiovascular Disease
- Interventions
- Dietary Supplement: Folic acid 2 mg + vitamin B12 1 mg dailyDrug: Placebo
- First Posted Date
- 2005-07-26
- Last Posted Date
- 2012-02-01
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 12064
- Registration Number
- NCT00124072
- Locations
- π¬π§
CTSU, Richard Doll Building, University of Oxford, Oxford, Oxon, United Kingdom
An Evaluation of the Effectiveness of a Simple Marketing Intervention in Changing Student Attitudes to Depression
Not Applicable
Completed
- Conditions
- Depression
- First Posted Date
- 2005-07-21
- Last Posted Date
- 2005-07-26
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 1680
- Registration Number
- NCT00122083
- Locations
- π¬π§
University of Oxford, Oxford, Oxfordshire, United Kingdom
Prolonged Tamoxifen Compared With Shorter Tamoxifen in Treating Patients Who Have Breast Cancer
Phase 3
- Conditions
- Breast Cancer
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2009-02-09
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 20000
- Registration Number
- NCT00003016
- Locations
- π¬π§
Atlas Trial Office, Oxford, England, United Kingdom